We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-3.38%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$43.6M
AUM Growth
-$446M
Cap. Flow
-$442M
Cap. Flow %
-1,013.48%
Top 10 Hldgs %
28.16%
Holding
580
New
77
Increased
4
Reduced
27
Closed
472

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.24M
2
TSM icon
TSMC
TSM
+$1.13M
3
SMR icon
NuScale Power
SMR
+$1.11M
4
TTD icon
Trade Desk
TTD
+$1.02M
5
MCHP icon
Microchip Technology
MCHP
+$910K

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$5.39M
2
ACN icon
Accenture
ACN
+$5.35M
3
CRWV
CoreWeave
CRWV
+$4.97M
4
HOOD icon
Robinhood
HOOD
+$4.87M
5
EXPE icon
Expedia Group
EXPE
+$4.81M

Sector Composition

Rank Sector Weight
1 Technology 25.63%
2 Healthcare 13.02%
3 Communication Services 12.94%
4 Consumer Discretionary 11.11%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
251
Encompass Health
EHC
$11.5B
-3,635
Closed -$462K
EIX icon
252
Edison International
EIX
$30.7B
-18,500
Closed -$1.02M
ELME
253
Elme Communities
ELME
$142M
-13,900
Closed -$234K
ELS icon
254
Equity Lifestyle Properties
ELS
$12.8B
-6,000
Closed -$364K
ELV icon
255
Elevance Health
ELV
$83.7B
-5,600
Closed -$1.81M
EME icon
256
Emcor
EME
$31.4B
-613
Closed -$398K
ENPH icon
257
Enphase Energy
ENPH
$4.79B
-15,288
Closed -$541K
EOG icon
258
EOG Resources
EOG
$74.4B
-3,700
Closed -$415K
EPRT icon
259
Essential Properties Realty Trust
EPRT
$6.94B
-11,100
Closed -$330K
ESTC icon
260
Elastic
ESTC
$6.46B
-10,800
Closed -$912K
EVLV icon
261
Evolv Technologies
EVLV
$1.01B
-19,700
Closed -$149K
EVTC icon
262
Evertec
EVTC
$1.94B
-11,837
Closed -$400K
EW icon
263
Edwards Lifesciences
EW
$48.2B
-42,100
Closed -$3.27M
EXC icon
264
Exelon
EXC
$48.4B
-9,625
Closed -$433K
EXLS icon
265
EXL Service
EXLS
$4.66B
-11,800
Closed -$520K
EXPE icon
266
Expedia Group
EXPE
$35.5B
-22,500
Closed -$4.81M
EXTR icon
267
Extreme Networks
EXTR
$3.92B
-14,153
Closed -$292K
EYE icon
268
National Vision
EYE
$1.75B
-16,800
Closed -$490K
FANG icon
269
Diamondback Energy
FANG
$53.5B
-7,333
Closed -$1.05M
FCX icon
270
Freeport-McMoran
FCX
$88.6B
-66,500
Closed -$2.61M
FERG icon
271
Ferguson
FERG
$45B
-15,400
Closed -$3.46M
FFIV icon
272
F5
FFIV
$22.8B
-13,200
Closed -$4.27M
FIS icon
273
Fidelity National Information Services
FIS
$23.2B
-17,700
Closed -$1.17M
FITB
274
Fifth Third Bancorp
FITB
$52.4B
-8,318
Closed -$371K
FIVN icon
275
FIVE9
FIVN
$2.08B
-22,275
Closed -$539K

Similar funds

Bayesian Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.

  • Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
  • Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
  • Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
  • Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
  • Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
  • Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
  • Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.